ROS-responsive dimeric prodrug-based nanomedicine targeted therapy for gastric cancer

• Main Authors: Jiachi Ma (Author), Yuzhong Chen (Author), Wanqing Liang (Author), Lei Li (Author), Jun Du (Author), Chengwu Pan (Author), Chensong Zhang (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Gastric cancer (GC) remains a major public health problem. Ursolic acid (UA) is reported to be effective in inhibiting GC; however, its low solubility and poor biocompatibility have greatly hindered its clinical application. Herein, an innovative reactive oxygen species (ROS)-sensitive UA dimeric pr...